Junmin Li
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 53
- Chronic Myeloid Leukemia Treatments 14
- Biochemistry top 2%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 15
- Molecular Biology top 5%
- Retinoids in leukemia and cellular processes 22
- Cancer Research top 5%
-
- Lymphoma Diagnosis and Treatment 24
-
- Acute Lymphoblastic Leukemia research 15
-
- Viral-associated cancers and disorders 12
- CAR-T cell therapy research 11
- Cited by
- HematologyBiochemistryGenetics
- Journals
- Blood (21 papers)Annals of Hematology (8 papers)Proceedings of the National Academy of Sciences (5 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Junmin Li
172 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 139
- Hematology 1.2k
- Biochemistry 257
- Genetics 318
- Molecular Biology 1.9k
- Cancer Research 384
Countries citing papers authored by Junmin Li
This map shows the geographic impact of Junmin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmin Li more than expected).
Fields of papers citing papers by Junmin Li
This network shows the impact of papers produced by Junmin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmin Li. The network helps show where Junmin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junmin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 15 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 52 | |
| 17 | 2019 | 1 | |
| 18 | 2018 | 2 | |
| 19 | 2018 | 24 | |
| 20 | 2015 | 2 |
About Junmin Li
Junmin Li is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 189 papers that have together received 3.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (53 papers), Lymphoma Diagnosis and Treatment (24 papers), Retinoids in leukemia and cellular processes (22 papers), Chronic Lymphocytic Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (15 papers), Chronic Myeloid Leukemia Treatments (14 papers), Viral-associated cancers and disorders (12 papers) and CAR-T cell therapy research (11 papers). The work is most often cited by research in Hematology (1.2k citations), Biochemistry (257 citations), Genetics (318 citations), Molecular Biology (1.9k citations) and Cancer Research (384 citations). Junmin Li has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Sai‐Juan Chen, Zhixiang Shen, Jian‐Qing Mi, Wen Wu, Samuel Waxman, Wenbin Xu, Yang Shen, Zhu Chen, Yongmei Zhu and Jiong Hu. Their work appears in journals such as Blood, Annals of Hematology, Proceedings of the National Academy of Sciences, Leukemia Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.